Musk’s Neuralink sight implant gets FDA ‘breakthrough’ status. What is it

The US FDA has awarded breakthrough device status to Neuralink’s Blindsight, an experimental implant designed to restore vision. Developed by Elon Musk’s company, the device aims to assist individuals who have lost their sight or were born blind. Initially offering low-resolution vision, it holds potential for future enhancements that may exceed natural sight.